Bausch + Lomb Reports First Quarter 2026 Revenue Growth Across Key Brands, Raises Full-Year Guidance

Published on April 30, 2026
VAUGHAN, Ontario—Global eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO) yesterday announced its first quarter 2026 financial results and raised its 2026 guidance. Total reported revenue was $1.244 billion for the first quarter of 2026, as compared with $1.137 billion in the first quarter of 2025, an increase of $107 million, or 9 percent. Excluding the favorable impact of foreign exchange of $42 million, revenue increased by approximately 6 percent on a constant currency basis compared with the first quarter of 2025. Bausch + Lomb also reported that it is raising its 2026 full-year revenue guidance by $45 million to a range of $5.42 billion to $5.52 billion from the previous range of $5.375 billion to $5.475 billion.
Continue reading on website
Other news

New Contact Lens Update Spotlights the Benefits of Prescribing Contact Lenses for Children

April 30, 2026
WATERLOO, Ontario—The Centre for Ocular Research & Education (CORE) has published Issue 89 of Contact Lens Update, which focuses on contact lenses for a rapidly growing demographic in eyecare practices: the pediatric population. “Contact lenses are being increasingly prescribed to younger patients,” said Jill Woods, head of clinical research at CORE. “They can positively impact the lives of many c

What is ‘good’ malpractice insurance coverage for optometrists? A practical checklist

April 30, 2026
Not all malpractice insurance is created equally. Learn what “good” coverage really means for doctors of optometry, including defense coverage, limits and portability, so you can confidently evaluate your policy.